Reticulocyte Hemoglobin Content and the Diagnosis of Iron Deficiency
This educational resource is supported by an
unrestricted educational grant from
Diagnosis of iron deficiency in hemodialysis patients is limited by the
inaccuracy of commonly used tests. Reticulocyte hemoglobin content (CHr) is
a test that has shown promise for improved diagnosis in preliminary studies.
In this Private Lecture Series™ program, Reticulocyte Hemoglobin Content In the Diagnosis of
Iron Deficiency In Hemodialysis Patients, Dr. Steven Fishbane, Director of
Dialysis Services and Associate Chairman of the Department of Medicine at
Winthrop University Hospital, Mineola, New York, presents data on the use
of CHr as a test for iron deficiency in hemodialysis patients.
Use the link below to access this Private Lecture™ on Bloodline.
Reticulocyte Hemoglobin Content In the Diagnosis of
Iron Deficiency In Hemodialysis Patients
